FMCCE 2026
Selected References
Safety, Dosing, and Quality: From Device Toxicology to Edible Pharmacokinetics
May 30, 2026 · 9th Annual Florida Medical Cannabis Conference & Expo
- 1.Love, C.A., Porter, N.A., Kim, H.Y.H., & Jaspers, I. Cannabinoid vaping products: Regulation, composition, toxicological effects, and emerging research. Chemical Research in Toxicology, 38(12), 2028–2040. https://doi.org/10.1021/acs.chemrestox.5c00240
- 2.Munger, K.R., Anreise, K.M., & Strongin, R.M. Cannabis concentrate vaping chemistry. Frontiers in Toxicology, 7. https://doi.org/10.3389/ftox.2025.1568207
- 3.Gaur, S. & Agnihotri, R. Heavy metals in cannabis vapes and their health implications: A scoping review. The Scientific World Journal, 2025, 9529544. https://doi.org/10.1155/tswj/9529544
- 4.Huestis, M.A. Human cannabinoid pharmacokinetics. Chemistry & Biodiversity, 4(8), 1770–1804. https://doi.org/10.1002/cbdv.200790152
- 5.Society of Cannabis Clinicians. Aspergillus in cannabis: Evaluating the evidence and crafting sensible policies. (2025). https://www.cannabisclinicians.org/2025/03/31/aspergillus-in-cannabis-evaluating-the-evidence-and-crafting-sensible-policies/
- 6.Florida Department of Health, Office of Medical Marijuana Use. Rules 64-4.016, 64ER25-5, 64ER25-6. (2026). https://knowthefactsmmj.com/rules-and-regulations/
- 7.Reuters. Testing turmoil: Legal and business implications of inconsistent cannabis testing standards. (2025). https://www.reuters.com/legal/litigation/testing-turmoil-legal-business-implications-inconsistent-cannabis-testing-2025-04-25/
Joseph Rosado, MD, MBA · rosadoadvisory.com